Cutaneous melanoma: new advances in treatment
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the use of cytokines such as interferon and interleukin become treatment options. In 2011, new drugs were approved by th...
Saved in:
Main Authors: | Michele Ceolin Foletto (Author), Sandra Elisa Haas (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Advances in Melanoma
Published: (2022) -
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
by: Riccardo Marconcini, et al.
Published: (2022) -
Cutaneous Melanoma
Published: (2020) -
Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy
by: Howa Yeung, et al.
Published: (2023) -
Cutaneous Side Effects of BRAF Inhibitors in Advanced Melanoma: Review of the Literature
by: Bilgen Gençler, et al.
Published: (2016)